Measurement Invariance of DSM-IV Alcohol, Marijuana and Cocaine Dependence Between Community-sampled and Clinically Overselected Studies
Overview
Authors
Affiliations
Aims: To examine whether DSM-IV symptoms of substance dependence are psychometrically equivalent between existing community-sampled and clinically overselected studies.
Participants: A total of 2476 adult twins born in Minnesota and 4121 unrelated adult participants from a case-control study of alcohol dependence.
Measurements: Life-time DSM-IV alcohol, marijuana and cocaine dependence symptoms and ever use of each substance.
Design: We fitted a hierarchical model to the data, in which ever use and dependence symptoms for each substance were indicators of alcohol, marijuana or cocaine dependence which were, in turn, indicators of a multi-substance dependence factor. We then tested the model for measurement invariance across participant groups, defined by study source and participant sex.
Findings: The hierarchical model fitted well among males and females within each sample [comparative fit index (CFI) > 0.96, Tucker-Lewis index (TLI) > 0.95 and root mean square error of approximation (RMSEA) < 0.04 for all], and a multi-group model demonstrated that model parameters were equivalent across sample- and sex-defined groups (ΔCFI = 0.002 between constrained and unconstrained models). Differences between groups in symptom endorsement rates could be expressed solely as mean differences in the multi-substance dependence factor.
Conclusions: Life-time substance dependence symptoms fitted a dimensional model well. Although clinically overselected participants endorsed more dependence symptoms, on average, than community-sampled participants, the pattern of symptom endorsement was similar across groups. From a measurement perspective, DSM-IV criteria are equally appropriate for describing substance dependence across different sampling methods.
Matson T, Hallgren K, Lapham G, Oliver M, Wang X, Williams E JAMA Netw Open. 2023; 6(5):e2316283.
PMID: 37234003 PMC: 10220521. DOI: 10.1001/jamanetworkopen.2023.16283.
Vize C, Lane S Assessment. 2021; 29(5):925-939.
PMID: 33615848 PMC: 9303006. DOI: 10.1177/1073191120986613.
Howe L, Fisher L, Atkinson E, Finn P Alcohol. 2020; 90:19-25.
PMID: 33232791 PMC: 7854477. DOI: 10.1016/j.alcohol.2020.11.002.
Examining the Utility of a General Substance Use Spectrum Using Latent Trait Modeling.
Bailey A, Finn P Drug Alcohol Depend. 2020; 212:107998.
PMID: 32362437 PMC: 7293921. DOI: 10.1016/j.drugalcdep.2020.107998.
A Decline in Propensity Toward Risk Behaviors Among U.S. Adolescents.
Borodovsky J, Krueger R, Agrawal A, Grucza R J Adolesc Health. 2019; 65(6):745-751.
PMID: 31521512 PMC: 6874743. DOI: 10.1016/j.jadohealth.2019.07.001.